Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Journal of Neuroimmunology
|
May 1, 1993
The origin of the autoimmune disease-resistant LER rat: an outcross between the buffalo and autoimmune disease-prone Lewis inbred rat strains
E A Goldmuntz, R L Wilder, Y Goldfarb, et al.
Obesity Research
|
March 1, 1997
The rat corpulent (cp) mutation maps to the same interval on (Pgm1-Glut1) rat chromosome 5 as the fatty (fa) mutation
E B Kahle, K G Butz, S C Chua, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 1, 1989
Effect of dietary carbohydrates on insulin and glucagon receptors in a new model of noninsulin-dependent diabetes-SHR/N-corpulent rat
S J Bhathena, B W Kennedy, J Jones, et al.
Brain Research. Molecular Brain Research
|
June 1, 1996
Early upregulation of medium neurofilament gene expression in developing spinal cord of the wobbler mouse mutant
R Pernas-Alonso, A E Schaffner, C Perrone-Capano, et al.
Diabetes, Obesity & Metabolism
|
November 13, 2014
Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy
P Hollander, A B King, S Del Prato, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1991
FVB/N: an inbred mouse strain preferable for transgenic analyses
M Taketo, A C Schroeder, L E Mobraaten, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 29, 2013
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial
B W Bode, J B Buse, M Fisher, et al.
Diabetes
|
January 1, 1982
Metabolic and underlying causes of diabetes mellitus
G M Grodsky, C E Anderson, D L Coleman, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Journal of Neuroimmunology
|
May 1, 1993
The origin of the autoimmune disease-resistant LER rat: an outcross between the buffalo and autoimmune disease-prone Lewis inbred rat strains
E A Goldmuntz, R L Wilder, Y Goldfarb, et al.
Obesity Research
|
March 1, 1997
The rat corpulent (cp) mutation maps to the same interval on (Pgm1-Glut1) rat chromosome 5 as the fatty (fa) mutation
E B Kahle, K G Butz, S C Chua, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
October 1, 1989
Effect of dietary carbohydrates on insulin and glucagon receptors in a new model of noninsulin-dependent diabetes-SHR/N-corpulent rat
S J Bhathena, B W Kennedy, J Jones, et al.
Brain Research. Molecular Brain Research
|
June 1, 1996
Early upregulation of medium neurofilament gene expression in developing spinal cord of the wobbler mouse mutant
R Pernas-Alonso, A E Schaffner, C Perrone-Capano, et al.
Diabetes, Obesity & Metabolism
|
November 13, 2014
Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy
P Hollander, A B King, S Del Prato, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1991
FVB/N: an inbred mouse strain preferable for transgenic analyses
M Taketo, A C Schroeder, L E Mobraaten, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 29, 2013
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial
B W Bode, J B Buse, M Fisher, et al.
Diabetes
|
January 1, 1982
Metabolic and underlying causes of diabetes mellitus
G M Grodsky, C E Anderson, D L Coleman, et al.
Page
of 7